Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Terbutaline

A selective beta-2 agonist bronchodilator developed in Sweden, patented in 1966 and in use since 1970: it relaxes the airway muscles and is used as a 'reliever' in asthma and other conditions with bronchospasm. This family brings together the active ingredient, pharmacopoeial impurities, nitrosamines and other impurities.

Did you know?Compared with adrenaline it lacks a hydroxyl group at position 4 of the ring: this lets it escape the enzyme COMT and act for longer, while its tert-butyl group makes it selective for beta-2 receptors.

TerbutalineGo to the active ingredient →
TerbutalineActive ingredientTerbutalineCat. No. P-T059-001CAS 23031-25-6

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.